Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

iCAD partners ACR Image Metrix to start clinical tests on virtual colonoscopy CAD system

ICAD : 23 January, 2008  (New Product)
iCAD has reached an agreement with ACR Image Metrix to conduct a multi-reader clinical study of iCAD's CT Colon product, for use with virtual colonoscopy.
iCAD will work with ACR Image Metrix to develop and execute a clinical study to support US Food and Drug Administration (FDA) approval of CT Colon CAD. ACR Image Metrix was launched by the American College of Radiology (ACR) to apply over thirty years of experience in conducting clinical research in part through the American College of Radiology Imaging Network (ACRIN).

The ACR and the ACRIN have a proven history in developing trials that standardise the use of imaging technologies, image transmission and archive, reduce the size and cost of trials and produce more reliable results.

'This partnership represents a major step forward in the development of our Colon CAD product,' said Ken Ferry, president and chief executive officer of iCAD. 'We feel that working with ACR Image Metrix, a group with significant expertise in radiology clinical trial management, will put us in an optimal position to submit solid clinical data to FDA and meet our goals for this important product line.'

Although 140,000 people in the USA will be diagnosed with colon cancer this year, it is one of the most treatable cancers when detected early. More than 82 million Americans are over 50 and are eligible for colorectal cancer screening, however the test is significantly under utilised, and due at least in part to the invasive nature of current screening procedures.

Results from recent trials showing the effectiveness of Virtual Colonoscopy as a screening procedure coupled with recent legislation introduced to establish Medicare reimbursement for the procedure are likely to expand the options available for colorectal cancer screening and increase utilisation of virtual colonoscopy.

'It is clear from the low compliance levels that we need more options in colon cancer screening,' said Bruce J Hillman, MD, FACR, ACR Image Metrix director of scientific affairs. 'We feel that CT Colonography has the potential to drastically improve colon cancer screening and we look forward to exploring how CAD can impact and enhance this new option for detecting polyps.'

Dr Hillman was the chair of ACRIN and played a pivotal role in advancing several national trials including the National CT Colonography Trial that recently demonstrated that CTC is highly accurate for the detection of intermediate and large polyps and that the accuracy of CTC is similar to colonoscopy.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo